Heath Skinner, MD, PhD, discussed the 3 considerations that determine which new radiation oncology service lines his network chooses to build.
The study found that patients exhibited a low rate of severe side effects after returning home, supporting less-intensive ...
Heath Skinner, MD, PhD, discussed which new radiation oncology service lines community practices can implement, how leadership decides, and what launches require.
Presentations at ESMO Congress 2026 detailed how surgery, radiation oncology, and supportive care can contribute to the ...
The investigators report that the phase 1 portion of the COMPARE trial met its safety end point and cleared the study to ...
Dwight H. Owen, MBBCh, MS, discussed why severe immune-related toxicities remain hard to predict as immunotherapy ...
If it is successful, you should be able to access this combination wherever you are,” said Natalie S. Callander, MD, of the ...
A bispecific in biliary tract cancer, dostarlimab organ preservation in rectal cancer, and KRAS G12D data in pancreatic cancer stood out at ESMO 2026.
Zev A. Wainberg, MD, MSc, discussed why neither the first-line regimen nor the second-line chemotherapy comparator altered ...
Bispecific antibodies targeting PD-L1 showed activity across first-, second-, and later-line advanced neuroendocrine ...
In a phase 3 trial, the Breast Cancer Locator was noninferior to wire localization and lowered positive margin rates in ...
ESMO 2026 posters showed durable EV-302 benefit in older and comorbid populations plus persistent early mortality in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results